Fortaleza Asset Management Inc. continued to hold its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,145 shares of the pharmacy operator’s stock at the end of the second quarter. Fortaleza Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $325,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of WBA. Waldron LP boosted its stake in shares of Walgreens Boots Alliance by 67.7% during the first quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock valued at $373,000 after purchasing an additional 1,816 shares during the period. Rhumbline Advisers boosted its stake in shares of Walgreens Boots Alliance by 3.3% during the first quarter. Rhumbline Advisers now owns 1,470,541 shares of the pharmacy operator’s stock valued at $122,128,000 after purchasing an additional 46,765 shares during the period. First Trust Advisors LP boosted its stake in shares of Walgreens Boots Alliance by 9.0% during the first quarter. First Trust Advisors LP now owns 389,554 shares of the pharmacy operator’s stock valued at $32,352,000 after purchasing an additional 32,140 shares during the period. MCF Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 68.2% during the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after purchasing an additional 780 shares during the period. Finally, Iron Financial LLC boosted its stake in shares of Walgreens Boots Alliance by 7.4% during the first quarter. Iron Financial LLC now owns 2,929 shares of the pharmacy operator’s stock valued at $243,000 after purchasing an additional 202 shares during the period. 60.14% of the stock is owned by institutional investors.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 67.31 on Tuesday. The firm has a 50-day moving average of $78.27 and a 200-day moving average of $80.61. The company has a market capitalization of $72.03 billion, a P/E ratio of 17.00 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a one year low of $67.21 and a one year high of $89.69.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 13.50% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/10/17/fortaleza-asset-management-inc-has-325000-holdings-in-walgreens-boots-alliance-inc-wba.html.

A number of analysts have recently issued reports on WBA shares. Morgan Stanley reissued an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Raymond James Financial, Inc. reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. SunTrust Banks, Inc. set a $72.00 target price on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday. Finally, Royal Bank Of Canada started coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 target price for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have issued a buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus price target of $90.18.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.